The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12) to Merck Sharp & Dohme LLC, doing business as Merck. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule.
The contract has a ceiling value of $5,837,161,580.00 and a period of performance from June 1, 2025, to May 31, 2030. Through this IDV, Merck will provide a comprehensive range of pharmaceutical products and vaccines to various federal agencies, including the Department of Veterans Affairs, Centers for Disease Control and Prevention, Department of Defense, Department of Health and Human Services, and the Office of the Assistant Secretary for Preparedness and Response. Key products include cancer drugs like Welireg (belzutifan), vaccines such as MMR and VARIVAX, and COVID-19 related treatments like molnupiravir. The contract does not utilize any set-aside designations, indicating an open and competitive procurement process.
Generated 5/23/25, 10:10 AM